Free Trial
ASX:AYA

Artrya (AYA) Stock Price, News & Analysis

Artrya logo

About Artrya Stock (ASX:AYA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$78.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Receive AYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artrya and its competitors with MarketBeat's FREE daily newsletter.

AYA Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
Automobiles And Trucks
Current Symbol
ASX:AYA
CIK
N/A
Fax
N/A
Employees
19,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$197,000.00
Price / Cash Flow
N/A
Book Value
A$0.21 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$78.67 million
Optionable
Not Optionable
Beta
0.71
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (ASX:AYA) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners